By Chris Wack

 

iRhythm Technologies Inc. said Friday it received FDA 510(k) clearance for its Zio ECG Utilization Software System for the Zio Watch.

The ZEUS system is produced in partnership with Verily, an Alphabet precision health company.

The ZEUS System is the AI algorithm and solution component of the Zio Watch, a sensor-based wearable for noninvasive, clinical grade, long-term continuous monitoring for atrial fibrillation.

Verily also received FDA 510(k) clearance for the Zio Watch.

iRhythm plans to introduce the ZEUS System for a limited market evaluation in 2023.

 

Write to Chris Wack at chris.wack@wsj.com

 

(END) Dow Jones Newswires

July 22, 2022 08:59 ET (12:59 GMT)

Copyright (c) 2022 Dow Jones & Company, Inc.
Alphabet (NASDAQ:GOOG)
Historical Stock Chart
From Sep 2022 to Oct 2022 Click Here for more Alphabet Charts.
Alphabet (NASDAQ:GOOG)
Historical Stock Chart
From Oct 2021 to Oct 2022 Click Here for more Alphabet Charts.